Hookipa Biotech
Latest round
- Series D
Last raised
- Feb 2019
Total raised
- $144M
Investors
- 13
About Hookipa Biotech
Founded in 2011 and headquartered in New York, US, Hookipa Biotech GmbH specializes in immunotherapy development. In December 2023, Gilead Sciences, Inc.47 per share., subject to certain terms and conditions. Following the deal, Gilead Sciences, Inc.4% minority stake in Hookipa Biotech GmbH. The acquisition enables Gilead Sciences, Inc. to advance its HIV program through Phase 1 trial. Hookipa Pharma specializes in developing innovative immunotherapy solutions aimed at reprogramming the immune system to effectively target and combat cancer and infectious diseases. Their proprietary arenaviral platform is designed to engineer therapeutics that amplify the body’s natural immune response, specifically focusing on mobilizing CD8+ T cells and antibodies. These therapeutics enhance the specificity, quantity, and quality of immune responses, addressing significant unmet medical needs in oncology and infectious disease treatment. Their product offerings primarily target healthcare providers, research institutions, and pharmaceutical partners across North America, Europe, and select regions in Asia, where advanced cancer therapies are in demand, benefiting patients affected by various types of cancers and infectious diseases.
Who invested in Hookipa Biotech
13 investors across 4 rounds
See all investors in Hookipa Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Hookipa Biotech
Who invested in Hookipa Biotech?
Hookipa Biotech has 13 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hookipa Biotech raised?
Hookipa Biotech has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Hookipa Biotech last raise money?
Hookipa Biotech's most recent round on record is a Series D, in Feb 2019.
What does Hookipa Biotech do?
Founded in 2011 and headquartered in New York, US, Hookipa Biotech GmbH specializes in immunotherapy development.
Where is Hookipa Biotech headquartered?
Hookipa Biotech is headquartered in New York, US.
Which VCs invest in companies like Hookipa Biotech?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Hookipa Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Hookipa Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.